- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alkem Laboratories Limited — Updates, 13-02-2026: Amendment(s)
13-02-2026 | 02:04 pm
13-02-2026 | 02:04 pm
Alkem's subsidiary Enzene Biosciences will raise ₹26.16 Cr via preferential allotment of securities to F-Prime Capital and ERVI Healthcare. This amendment to the Shareholders’ Agreement strengthens Enzene’s capital base.
No comments yet. Be the first to comment!